• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Brookdale Senior Living Inc. (Amendment)

    2/14/24 4:46:08 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care
    Get the next $BKD alert in real time by email
    SC 13G/A 1 sayw24021423_13ga.htm


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549



    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. 5)*

    BROOKDALE SENIOR LIVING INC.
    (Name of Issuer)

    Common Stock, $0.01 par value per share
    (Title of Class of Securities)

    112463104
    (CUSIP Number)

    December 31, 2023
    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)
    ☒ Rule 13d-1(c)
    ☐ Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    Continued on following pages
    Page 1 of 10 Pages
    Exhibit Index: Page 8



    CUSIP No. 112463104
    Page 2 of 10 Pages
    1
    NAMES OF REPORTING PERSONS
     
     
    GLENVIEW CAPITAL MANAGEMENT, LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    16,944,673
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    16,944,673
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    16,944,673
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    9.00%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    OO
     
     
     
     


    CUSIP No. 112463104
    Page 3 of 10 Pages
    1
    NAMES OF REPORTING PERSONS
     
     
    LARRY ROBBINS
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    United States of America
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    16,944,673
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    16,944,673
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    16,944,673
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    9.00%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    IN, HC
     
     
     
     


    CUSIP No. 112463104
    Page 4 of 10 Pages
    Item 1(a).
    Name of Issuer:

    Brookdale Senior Living Inc. (the “Issuer”)

    Item 1(b).
    Address of Issuer’s Principal Executive Offices:

    111 Westwood Place, Suite 400, Brentwood, Tennessee 37027

    Item 2(a).
    Name of Person Filing

    This Statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

     
    i)
    Glenview Capital Management, LLC (“Glenview Capital Management”);

     
    ii)
    Larry Robbins (“Mr. Robbins”).

    This Statement relates to Shares (as defined herein) held for the accounts of Glenview Capital Partners, L.P., a Delaware limited partnership (“Glenview Capital Partners”), Glenview Capital Master Fund, Ltd., a Cayman Islands exempted company (“Glenview Capital Master Fund”), Glenview Offshore Opportunity Master Fund, Ltd., a Cayman Islands exempted company (“Glenview Offshore Opportunity Master Fund”), Glenview Capital Opportunity Fund, L.P., a Delaware limited partnership (“Glenview Capital Opportunity Fund”), and Glenview Healthcare Master Fund, L.P., a Cayman Islands limited partnership (“Glenview Healthcare Master Fund”).

    Glenview Capital Management serves as investment manager to each of Glenview Capital Partners, Glenview Capital Master Fund, Glenview Offshore Opportunity Master Fund, Glenview Capital Opportunity Fund, and Glenview Healthcare Master Fund. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management.

    Item 2(b).
    Address of Principal Business Office or, if None, Residence:

    The address of the principal business office of each of Glenview Capital Management and Mr. Robbins is 767 Fifth Avenue, 44th Floor, New York, New York 10153.

    Item 2(c).
    Citizenship:

     
    i)
    Glenview Capital Management is a Delaware limited liability company;

     
    ii)
    Mr. Robbins is a citizen of the United States of America.

    Item 2(d).
    Title of Class of Securities:

    Common Stock, $0.01 par value per share (the “Shares”)

    Item 2(e).
    CUSIP Number:

    112463104


    CUSIP No. 112463104
    Page 5 of 10 Pages
    Item 3.
    If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

    This Item 3 is not applicable.

    Item 4.
    Ownership:

    Item 4(a)
    Amount Beneficially Owned:

    As of December 31, 2023, each of Glenview Capital Management and Mr. Robbins may be deemed the beneficial owner of 16,944,673 Shares. This amount consists of: (A) 718,558 Shares held for the account of Glenview Capital Partners; (B) 6,680,022 Shares held for the account of Glenview Capital Master Fund; (C) 2,144,645 Shares held for the account of Glenview Offshore Opportunity Master Fund; (D) 6,833,396 Shares held for the account of Glenview Capital Opportunity Fund; and (E) 568,052 Shares held for the account of Glenview Healthcare Master Fund.

    Item 4(b)
    Percent of Class:

    As of December 31, 2023, each of the Reporting Persons may be deemed the beneficial owner of approximately 9.00% of Shares outstanding. (There were 188,238,130 Shares outstanding as of November 3, 2023, based on the Issuer’s quarterly report on Form 10-Q, filed on November 7, 2023.)

    Item 4(c)
    Number of Shares as to which such person has:

    (i) Sole power to vote or direct the vote:
    0
    (ii) Shared power to vote or direct the vote:
    16,944,673
    (iii) Sole power to dispose or direct the disposition of:
    0
    (iv) Shared power to dispose or direct the disposition of:
    16,944,673

    Item 5.
    Ownership of Five Percent or Less of a Class:

    This Item 5 is not applicable.

    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person:

    See disclosure in Items 2 and 4 hereof. Certain funds listed in Item 2(a) are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by this Statement that may be deemed to be beneficially owned by the Reporting Persons.


    CUSIP No. 112463104
    Page 6 of 10 Pages
    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

    See disclosure in Item 2 hereof.

    Item 8.
    Identification and Classification of Members of the Group:

    This Item 8 is not applicable.

    Item 9.
    Notice of Dissolution of Group:

    This Item 9 is not applicable.

    Item 10.
    Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.


    CUSIP No. 112463104
    Page 7 of 10 Pages
    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    GLENVIEW CAPITAL MANAGEMENT, LLC
     
           
     
    By:
    /s/ Mark J. Horowitz
     
       
    Mark J. Horowitz
     
       
    Co-President of Glenview Capital Management, LLC
     
           
     
    LARRY ROBBINS
     
           
     
    By:
    /s/ Mark J. Horowitz
     
       
    Mark J. Horowitz, attorney-in-fact for Larry Robbins
     
           
    February 14, 2024
         


    CUSIP No. 112463104
    Page 8 of 10 Pages
    EXHIBIT INDEX
    Ex.
     
    Page No.
         
    A
    Joint Filing Agreement
    9
    B
    Power of Attorney
    10


    CUSIP No. 112463104
    Page 9 of 10 Pages
    EXHIBIT A

    JOINT FILING AGREEMENT

    The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Brookdale Senior Living Inc. dated as of February 14, 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

     
    GLENVIEW CAPITAL MANAGEMENT, LLC
     
           
     
    By:
    /s/ Mark J. Horowitz
     
       
    Mark J. Horowitz
     
       
    Co-President of Glenview Capital Management, LLC
     
           
     
    LARRY ROBBINS
     
           
     
    By:
    /s/ Mark J. Horowitz
     
       
    Mark J. Horowitz, attorney-in-fact for Larry Robbins
     
           
    February 14, 2024
         


    CUSIP No. 112463104
    Page 10 of 10 Pages
    EXHIBIT B

    POWER OF ATTORNEY

    KNOW ALL MEN BY THESE PRESENT, that I, Larry Robbins, hereby make, constitute and appoint Mark J. Horowitz, acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as Chief Executive Officer or in other capacities of Glenview Capital Management, LLC, a Delaware limited liability company, and each of its affiliates or entities advised or controlled by me or Glenview Capital Management, LLC, all documents, certificates, instruments, statements, filings and agreements (“documents”) to be filed with or delivered to any foreign or domestic governmental or regulatory body or required or requested by any other person or entity pursuant to any legal or regulatory requirement relating to the acquisition, ownership, management or disposition of securities, futures contracts or other investments, and any other documents relating or ancillary thereto, including, without limitation, all documents relating to filings with the United States Securities and Exchange Commission (the “SEC”) pursuant to the Securities Act of 1933, as amended, or the Securities and Exchange Act of 1934, as amended (the “Act”), and the rules and regulations promulgated thereunder, including, without limitation: (1) all documents relating to the beneficial ownership of securities required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of the Act, including, without limitation: (a) any acquisition statements on Schedule 13D or Schedule 13G and any amendments thereto, (b) any joint filing agreements pursuant to Rule 13d-1(k), and (c) any initial statements of, or statements of changes in, beneficial ownership of securities on Form 3, Form 4 or Form 5 and (2) any information statements on Form 13F required to be filed with the SEC pursuant to Section 13(f) of the Act.

    All past acts of the attorney-in-fact in furtherance of the foregoing are hereby ratified and confirmed.
    This Power of Attorney revokes the previous Power of Attorney, executed by the undersigned on February 10, 2009, and shall remain in effect until revoked, in writing, by the undersigned.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney, this 2nd day of February, 2016.

    /s/ Larry Robbins

    Larry Robbins



    Get the next $BKD alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BKD

    DatePrice TargetRatingAnalyst
    4/1/2025$7.00Equal Weight
    Barclays
    10/16/2024$8.00Buy
    Jefferies
    10/7/2024$7.75 → $6.00Neutral → Underperform
    BofA Securities
    6/28/2024$7.50Outperform
    Macquarie
    12/15/2023$3.95 → $6.00Underperform → Neutral
    BofA Securities
    11/17/2023$7.00 → $9.00Sector Perform → Outperform
    RBC Capital Mkts
    1/17/2023$5.00 → $4.00Buy → Hold
    Stifel
    8/9/2021$7.00 → $8.00Sector Perform
    RBC Capital
    More analyst ratings

    $BKD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Brookdale Announces Second Quarter 2025 Earnings Release and Conference Call Dates

      NASHVILLE, Tenn., July 23, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) plans to release its second quarter 2025 financial results after the market closes on Wednesday, August 6, 2025. The Company also plans to discuss the results on a conference call scheduled for Thursday, August 7, 2025, at 9:00 a.m. (ET). BROOKDALE SENIOR LIVING - EARNINGS CALLDate: Thursday, August 7, 2025Time: 9:00 a.m. (ET) / 8:00 a.m. (CT) Call Within US: +1 (800) 715-9871Call Outside US: +1 (646) 307-1963Conference ID: 1482282 A webcast of the conference call will be available to the p

      7/23/25 6:45:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Ortelius Comments on Results of Brookdale Senior Living Inc. Annual Meeting of Stockholders

      Ortelius' Public Campaign Has Driven Meaningful Change at Brookdale, Including the Dismissal of the Former CEO Ortelius Remains Committed to Holding the Board and Management Accountable for Performance and Actions to Maximize Value for Stockholders Ortelius Advisors, L.P. ("Ortelius") today issued the following statement in connection with its public campaign for change at Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company"), and the Company's Annual Meeting of Stockholders, which was held on July 11, 2025. Peter DeSorcy, Managing Member of Ortelius, said: "Ortelius' campaign served as an important catalyst for change at Brookdale, meaningfully impacting the Compan

      7/16/25 8:00:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Brookdale Reports June 2025 Occupancy

      NASHVILLE, Tenn., July 8, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) reported today its consolidated occupancy for June 2025.  June 2025 Observations: June consolidated occupancy results:Weighted average occupancy of 80.5% increased 230 basis points year-over-year and 50 basis points sequentially, reflecting occupancy acceleration during the quarter, which was driven both by higher move-ins and favorable move-out activity both year-over-year and sequentially.Month end consolidated occupancy was 82.2%, increasing 70 basis points sequentially and demonstrating continued strong demand and sales execution.June same community occupancy results:Weighted average occupancy of 81.1

      7/8/25 7:15:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    SEC Filings

    See more
    • Amendment: Brookdale Senior Living Inc. filed SEC Form 8-K: Leadership Update

      8-K/A - Brookdale Senior Living Inc. (0001332349) (Filer)

      7/15/25 5:10:55 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Brookdale Senior Living Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

      8-K - Brookdale Senior Living Inc. (0001332349) (Filer)

      7/15/25 5:00:50 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • SEC Form 144 filed by Brookdale Senior Living Inc.

      144 - Brookdale Senior Living Inc. (0001332349) (Subject)

      7/10/25 3:23:25 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Hicks George T bought $50,307 worth of shares (9,140 units at $5.50), increasing direct ownership by 3% to 351,883 units (SEC Form 4)

      4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      3/6/24 4:27:18 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Bumstead Frank M bought $5,360 worth of shares (1,000 units at $5.36), increasing direct ownership by 0.20% to 500,052 units (SEC Form 4)

      4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      2/23/24 4:28:41 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Former Officer Hicks George T returned 67,970 shares to the company, decreasing direct ownership by 18% to 314,631 units (SEC Form 4)

      4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      5/22/25 4:20:59 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Director Wielansky Lee S sold $68,235 worth of shares (10,000 units at $6.82), decreasing direct ownership by 4% to 223,836 units (SEC Form 4)

      4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      5/20/25 4:27:07 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • SEC Form 3 filed by new insider Hausman Joshua

      3 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      5/2/25 4:59:17 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Financials

    Live finance-specific insights

    See more
    • Brookdale Announces Second Quarter 2025 Earnings Release and Conference Call Dates

      NASHVILLE, Tenn., July 23, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) plans to release its second quarter 2025 financial results after the market closes on Wednesday, August 6, 2025. The Company also plans to discuss the results on a conference call scheduled for Thursday, August 7, 2025, at 9:00 a.m. (ET). BROOKDALE SENIOR LIVING - EARNINGS CALLDate: Thursday, August 7, 2025Time: 9:00 a.m. (ET) / 8:00 a.m. (CT) Call Within US: +1 (800) 715-9871Call Outside US: +1 (646) 307-1963Conference ID: 1482282 A webcast of the conference call will be available to the p

      7/23/25 6:45:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Ortelius Reaffirms Strategy to Unlock Sustainable Long-Term Value for Brookdale Senior Living Inc. Stockholders

      The Brookdale Board's Ongoing Missteps, Shortcomings, and Strategic Failures are Palpable, and Jeopardize the Company's Viability Contrary to the Current Board's Assertions, Ortelius' Strategy is Materially Different from the Company's Current Plans Ortelius' Nominees Would Restore Accountability at Brookdale, and Immediately Begin the Process of Substantial Value Generation for Stockholders Ortelius Advisors, L.P. ("Ortelius") today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD)("Brookdale" or the "Company"), which further outlines that the judgement, execution, and decision-making abilities of Brookdale's current Board of Directors

      6/16/25 8:00:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Ortelius Outlines Pathways to Build and Unlock Sustainable Long-Term Value for Brookdale Senior Living Inc. Stockholders

      Issues Letter to Stockholders that Identifies Multiple Paths to Value Creation for Brookdale Departure of Long Time CEO Cindy Baier in the Face of Ortelius' Campaign Just the First Step in Holding Board Accountable We Believe Ortelius' Nominees have the Skills and Experience Necessary to Oversee the Execution of Its Strategic Plan to Drive Real Change for Stockholders Ortelius Advisors, L.P. today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD). The full text of the letter follows: April 24, 2025 Fellow Brookdale Senior Living Stockholders, Over the past seven years, investors in Brookdale Senior Living Inc. ("Brookdale" or the "Compa

      4/24/25 8:00:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Leadership Updates

    Live Leadership Updates

    See more
    • Ortelius Issues Final Call to Action for Brookdale Senior Living Inc. Stockholders and Encourages a Vote for Urgent Change

      Three Independent Proxy Advisors Recommend Stockholders Vote FOR Ortelius Nominees to Advance a Necessary Turnaround and End Years of Underperformance at Brookdale Vote FOR Ortelius' Nominees on the WHITE Proxy Card to Restore Accountability at Brookdale, and Immediately Begin the Process of Value Generation for Stockholders Ortelius Advisors, L.P. ("Ortelius") today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company"), encouraging stockholders who have not yet voted to consider the current Board's abysmal performance, defensive tactics, dearth of responsibility, and questionable decision-making abilities. In i

      7/7/25 7:00:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Ortelius Director Nominees Release Joint Letter to Brookdale Stockholders

      Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock

      7/3/25 8:00:00 AM ET
      $BKD
      $GMRE
      $NTST
      $OHI
      Hospital/Nursing Management
      Health Care
      Real Estate Investment Trusts
      Real Estate
    • Glass Lewis Recommends Stockholders Vote for Change at Brookdale Senior Living Inc.

      Third Independent Proxy Advisor Confirms the Persuasive Case to Bolster Key Competencies on the Brookdale Board and Recommends Stockholders Vote FOR Ortelius Nominees to Advance a Necessary Turnaround Glass Lewis Identifies Governance Challenges at Brookdale Including the Persistent Lack of Accountability for Legacy Directors who have Overseen Poor Performance Furthering the Need for Board Renewal Ortelius Urges Brookdale Stockholders to Vote FOR all Six of Ortelius' Nominees on the WHITE Proxy Card Ortelius Advisors, L.P. ("Ortelius") today announced that a third leading independent proxy advisory firm, Glass, Lewis & Co. ("Glass Lewis"), has recommended that stockholders vote FOR th

      7/1/25 4:30:00 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Barclays initiated coverage on Brookdale Senior Living with a new price target

      Barclays initiated coverage of Brookdale Senior Living with a rating of Equal Weight and set a new price target of $7.00

      4/1/25 7:41:49 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Jefferies initiated coverage on Brookdale Senior Living with a new price target

      Jefferies initiated coverage of Brookdale Senior Living with a rating of Buy and set a new price target of $8.00

      10/16/24 7:19:46 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Brookdale Senior Living downgraded by BofA Securities with a new price target

      BofA Securities downgraded Brookdale Senior Living from Neutral to Underperform and set a new price target of $6.00 from $7.75 previously

      10/7/24 7:42:01 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Brookdale Senior Living Inc.

      SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

      11/14/24 4:43:24 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Brookdale Senior Living Inc.

      SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

      11/14/24 4:17:59 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by Brookdale Senior Living Inc. (Amendment)

      SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

      2/14/24 4:46:08 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care